Loading
JP
Jiangbo Pharmaceuticals, Inc. Stock: price and insider trades · United States
Jiangbo Pharmaceuticals, Inc.: what insiders have been doing
Insider filings for Jiangbo Pharmaceuticals, Inc. are scarce in the SEC (Form 4) feed, the latest one published on 29 July 2010. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 29 July 2010
Declarations6 total
1,250 shares0Common Stock, par value $0.001SEC:0001144204-10-040185:0
1,143 shares0Common Stock, par value $0.001SEC:0001144204-10-040185:1
914 shares0Common Stock, par value $0.001SEC:0001144204-10-038161:0
25,000 shares0Common StockSEC:0001144204-10-038300:0
1,250 shares0Common Stock, par value $0.001SEC:0001144204-10-037994:0
1,009 shares0Common Stock, par value $0.001SEC:0001144204-10-037994:1
6 of 6 declarations
About Jiangbo Pharmaceuticals, Inc.
Jiangbo Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceutical products. It is listed on NASDAQ under the ticker XNAS.
